Nordea Investment Management
RCUS icon

Nordea Investment Management’s Arcus Biosciences RCUS Stock Holding History

Nordea Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-328,459
Closed -$4.33M – 878
2025
Q3 		$4.33M Buy
328,459
+8,560
+3% +$89K ﹤0.01% 620
2025
Q2 		$2.63M Buy
319,899
+46,776
+17% +$400K ﹤0.01% 683
2025
Q1 		$2.08M Buy
273,123
+54,193
+25% +$628K ﹤0.01% 696
2024
Q4 		$3.24M Buy
218,930
+5,246
+2% +$85.7K ﹤0.01% 609
2024
Q3 		$3.31M Sell
213,684
-10,267
-5% -$162K ﹤0.01% 599
2024
Q2 		$3.37M Sell
223,951
-35,421
-14% -$572K ﹤0.01% 604
2024
Q1 		$4.89M Buy
259,372
+53,944
+26% +$933K 0.01% 543
2023
Q4 		$3.95M Sell
205,428
-6,356
-3% -$102K 0.01% 582
2023
Q3 		$3.79M Buy
211,784
+24,121
+13% +$485K 0.01% 562
2023
Q2 		$3.79M Sell
187,663
-75,423
-29% -$1.44M 0.01% 574
2023
Q1 		$4.81M Sell
263,086
-2,428
-0.9% -$46.4K 0.01% 528
2022
Q4 		$5.49M Buy
+265,514
New +$7.31M 0.01% 490

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Nordea Investment Management's RCUS Position: Q4 2025 in Review

Nordea Investment Management sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 328,459 shares — an estimated $4.33M sold.

Nordea Investment Management first reported a position in RCUS in Q4 2022 and held it in 12 quarters. The position peaked at $5.49M in Q4 2022. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • Nordea Investment Management reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
  • Nordea Investment Management sold 328,459 Arcus Biosciences shares in Q4 2025, an estimated $4.33M.
  • Nordea Investment Management first reported a position in Arcus Biosciences in Q4 2022 and held it in 12 quarters.
  • Nordea Investment Management's Arcus Biosciences position peaked at $5.49M in Q4 2022.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Nordea Investment Management's 13F filing for Q4 2025, filed 8 Jan 2026.